2A Biosciences develops small molecule drugs targeting inflammation through the use of 2A agonists. The company focuses on addressing the unmet medical needs associated with inflammatory diseases by enhancing the therapeutic efficacy of these compounds.

Anthropic develops AI models, including Claude 3.5 Sonnet, that prioritize safety in large-scale AI systems through techniques like Constitutional AI, which ensures harmlessness via AI feedback. The company addresses the risks associated with deploying advanced AI technologies by creating reliable and beneficial systems for enterprises.

The startup provides a platform for renting shared electric scooters, utilizing IoT technology to create a network that enhances urban mobility. This service addresses last-mile connectivity issues, reduces traffic congestion, and minimizes environmental impact through a pay-per-use model.

Bexson Biomedical is developing a subcutaneous delivery system for its BB106 non-opioid therapy, targeting acute pain management to provide an alternative to opioids. The company's formulation platform enhances the pharmacokinetics of existing drugs, enabling effective home health delivery and addressing the challenges of pain treatment without the risks associated with opioid use.

The startup offers an online astrology platform that connects users with verified astrologers for personalized daily horoscopes and guidance in astrology, yoga, tarot, and meditation. This service helps individuals make informed decisions and promotes mental and physical well-being by providing tailored insights to enhance their personal and professional lives.

Breathwrk is a mobile app that provides short, science‑backed breathing exercises to regulate the nervous system for stress relief, sleep improvement, focus, and athletic performance. Users can choose from over 50 guided sessions with visual, audio, and haptic cues, each lasting as little as 60 seconds and requiring no prior skill or equipment.

This startup provides road maintenance services that utilize proprietary on-site crushers to recycle existing road materials and a plant-based binder to replace traditional bitumen. By enabling the construction of carbon-negative roads, the company helps public and private road owners enhance sustainability and durability while reducing their carbon footprint.

Charm Industrial develops a technology that converts agricultural biomass into carbon-rich bio-oil through fast pyrolysis, which is then injected deep underground for permanent CO₂ storage. This process effectively removes carbon dioxide from the atmosphere, addressing the urgent need for reliable carbon removal solutions while producing green hydrogen as a byproduct.

Clerkenwell Health is a clinical research organization specializing in psychedelic therapies, utilizing a vetted patient database and experienced investigators to enhance access to psychiatric and central nervous system (CNS) trials. The company addresses the need for effective treatment options in psychiatric conditions by streamlining clinical development processes and improving patient recruitment.

This startup develops mental healthcare drugs and therapies focused on cognitive neuro-engineering. Their treatments aim to enhance desirable cognitive traits like mindfulness and mental acuity, helping individuals manage conditions such as stress, anxiety, and depression.

Reconnect Labs develops precision neuropsychiatric therapeutics and predictive diagnostics targeting insomnia, anxiety, and substance use disorders. Their platform combines engineered psychoactive formulations with disease‑modifying mechanisms to deliver both rapid symptom relief and long‑term therapeutic benefit. Leveraging expertise in neuroscience, psychopharmacology, and clinical research, they aim to create scalable, cost‑effective treatments for mental health conditions.